Authors: Ho, SP Takahashi, LK Livanov, V Spencer, K Lesher, T Maciag, C Smith, MA Rohrbach, KW Hartig, PR Arneric, SP

Citation: Sp. Ho et al., Attenuation of fear conditioning by antisense inhibition of brain corticotropin releasing factor-2 receptor, MOL BRAIN R, 89(1-2), 2001, pp. 29-40

Authors: Fitzgerald, LW Burn, TC Brown, BS Patterson, JP Corjay, MH Valentine, PA Sun, JH Link, JR Abbaszade, I Hollis, JM Largent, BL Hartig, PR Hollis, GF Meunier, PC Robichaud, AJ Robertson, DW

Citation: Lw. Fitzgerald et al., Possible role of valvular serotonin 5-HT2B receptors in the cardiopathy associated with fenfluramine, MOLEC PHARM, 57(1), 2000, pp. 75-81

Authors: Seiffert, D Bradley, JD Rominger, CM Rominger, DH Yang, FD Meredith, JE Tang, Q Roach, AH Thompson, LA Spitz, SM Higaki, JN Prakash, SR Combs, AP Copeland, RA Arneric, SP Hartig, PR Robertson, DW Cordell, B Stern, AM Olson, RE Zaczek, R

Citation: D. Seiffert et al., Presenilin-1 and-2 are molecular targets for gamma-secretase inhibitors, J BIOL CHEM, 275(44), 2000, pp. 34086-34091

Authors: Fitzgerald, LW Iyer, G Conklin, DS Krause, CM Marshall, A Patterson, JP Tran, DP Jonak, GJ Hartig, PR

Citation: Lw. Fitzgerald et al., Messenger RNA editing of the human serotonin 5-HT2C receptor, NEUROPSYCH, 21(2), 1999, pp. S82-S90

Authors: Fitzgerald, LW Conklin, DS Krause, CM Marshall, AP Patterson, JP Tran, DP Iyer, G Kostich, WA Largent, BL Hartig, PR

Citation: Lw. Fitzgerald et al., High-affinity agonist binding correlates with efficacy (intrinsic activity) at the human serotonin 5-HT2A and 5-HT2C receptors: Evidence favoring theternary complex and two-state models of agonist action, J NEUROCHEM, 72(5), 1999, pp. 2127-2134

Authors: Grzanna, R Dubin, JR Dent, GW Ji, ZQ Zhang, W Ho, SP Hartig, PR

Citation: R. Grzanna et al., Intrastriatal and intraventricular injections of oligodeoxynucleotides in the rat brain: tissue penetration, intracellular distribution and c-fos antisense effects, MOL BRAIN R, 63(1), 1998, pp. 35-52